Biogen to acquire Nightstar Therapeutics for $800M

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Monday, Biogen announced it would acquire Nightstar Therapeutics in the $800M worth cash-deal, amid company's intention to expand its footprint in the gene therapy market.

Actual Topics